Glenmark recalls 6,528 bottles of blood pressure drug in US
As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 14, 2024 Category: Pharmaceuticals Source Type: news

Atrium Health Wake Forest Baptist treats first local patient with FDA-approved Alzheimer ’s disease drug
On March 14, 2024, Atrium Health Wake Forest Baptist became the first health system in the region to treat a patient with lecanemab, a new medication for Alzheimer ’s disease. This is the first Alzheimer’s drug approved by the FDA in more than 20 years.* Alzheimer’s disease is a type of dementia that affects memory, thinking and behavior. It is a progressive disease, with symptoms gradually worsening over several years. Lecanemab slows the progression o f the disease by removing amyloid, a protein… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 14, 2024 Category: Biotechnology Authors: Atrium Health Wake Forest Baptist Source Type: news

Atrium Health Wake Forest Baptist honors the past with Davis Memorial Chapel
Since opening in 1923, North Carolina Baptist Hospital, now more commonly known as Atrium Health Wake Forest Baptist Medical Center, has undergone many physical changes, but one structure stands unaltered — Davis Memorial Chapel. It is a tangible link to the original hospital building and two key founders and remains a vital sanctuary for those involved in the healing work of the hospital. “Although the chapel reflects the Christian tradition, we work hard to create a hospitable place for people … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 14, 2024 Category: Biotechnology Authors: Atrium Health Wake Forest Baptist Source Type: news

New study to test long-term effects of weight loss drugs
Ozempic, Wegovy, Mounjaro — three new medications used to treat obesity — seemed to be all over the news and social media in 2023. You’ve likely seen or read about their effectiveness, their side effects, their cost and what happens when you quit taking them. But as we grapple with the increasing epidemic of obesity an d its complementary health issues, researchers at Wake Forest University School of Medicine are looking to an older, generic drug for answers. First approved by the Food and… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 14, 2024 Category: Biotechnology Authors: Atrium Health Wake Forest Baptist Source Type: news

Atrium Health Wake Forest Baptist driver “saving the day” for passengers
Richard Darwin “Dar” Hack is a driver at Atrium Health Wake Forest Baptist’s Van Services. He’s been with the organization on and off since 2016 and loves his job, often finding himself “saving the day” for passengers. Hack said, “Almost on a daily basis someone says, ‘You’re a godsend,’ ‘Y ou’ve been so helpful’ or something similar.” A former Air Force pilot in the 1980s, Hack was a bus driver with Winston-Salem/Forsyth County Schools for several years before joining… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 14, 2024 Category: Biotechnology Authors: Atrium Health Wake Forest Baptist Source Type: news

Biotech CEO who relied on multiple aliases sentenced to 7 years in prison for Theranos-like $28 million fraud involving a fake finger-prick Covid test
The CEO of a California biotech company, Decision Diagnostics, claimed to have a finger-prick test that could detect Covid-19 and used multiple fake identities to pump up the company’s stock price, authorities said. The CEO, Keith Berman, was sentenced on Friday to seven years in prison for the…#decisiondiagnostics #keithberman #departmentofjustice #nicoleargentieri #justicedepartments #criminaldivision #westlakevillage #matthewsteinmann #investorshangout #decisiondiagnostic (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2024 Category: Consumer Health News Source Type: news

Two Brothers, a Big Biotech Bet and an $8 Billion Payout
(Source: Reuters: Health)
Source: Reuters: Health - April 13, 2024 Category: Consumer Health News Source Type: news

Biotech Exec Gets 7 Years in Prison for False Claims About Rapid Covid-19 Test
The former chief executive of a biotechnology company who, during the early days of the pandemic, falsely claimed that he had invented a blood test that could detect Covid-19 in 15 seconds was sentenced on Friday to seven years in prison for securities fraud, federal prosecutors said. From…#keithberman #westlakevillage #genviro (Source: Reuters: Health)
Source: Reuters: Health - April 13, 2024 Category: Consumer Health News Source Type: news

Portage Biotech Explores Strategic Alternatives
has released an update. Portage Biotech Inc. is reassessing its strategic options, including potential asset sales, mergers,...#portagebiotechinc (Source: Reuters: Health)
Source: Reuters: Health - April 12, 2024 Category: Consumer Health News Source Type: news

Neuberg Diagnostics plans to raise $100 million to fund acquisitions
Neuberg, which runs a pan-India diagnostic chain, has appointed O3 Capital as the investment banker and is currently in talks with potential investors, Velu said in an interview. The Chennai-based company plans to use the fresh capital to expand its radiology business through acquisitions, chairman GSK Velu said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 12, 2024 Category: Pharmaceuticals Source Type: news

StrokeCP, digital health platform developed at Atrium Health Wake Forest Baptist, goes commercial
Winston-Salem startup CareDirections – spun off from research at Atrium Health Wake Forest Baptist – reached an important milestone this month for its proprietary digital health platform: commercialization. Here's how StrokeCP, created from a $14 million study, will help reduce the reoccurrence of strokes and related costs. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 12, 2024 Category: Biotechnology Authors: Lillian Johnson Source Type: news

Kaleida to begin search for hospital president
The current president will return to private medical practice when a new leader is named. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 12, 2024 Category: Biotechnology Authors: Tracey Drury Source Type: news

New Baptist Health hospital secures $58 million loan
The new hospital is expected to break ground soon. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 12, 2024 Category: Biotechnology Authors: Brian Bandell Source Type: news

Largest Nursing Homes in the Albany area
The largest nursing homes in the Capital Region. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 12, 2024 Category: Biotechnology Source Type: news

2023 Largest Denver-Area Biotechnology/Bioscience Cos.
Information on The 2023 Biotechnology/Bioscience Companies List was supplied by individual companies through questionnaires and cannot be independently verified by the Denver Business Journal. Novus Biologicals, Securisyn Medical and Transverse Medical Inc, ranked Nos. 4, 17 and 22 on last year ’s List, respectively, did not respond in time for publication. Heska Corporation, ranked No. 7 on last year’s List, was acquired by Virginia-based Mars Corp. in April 2023. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 12, 2024 Category: Biotechnology Source Type: news